Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de Hospital Virgen de la Concha](/img/noimage_org.png)
Hospital Virgen de la Concha
Zamora, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen de la Concha (38)
2023
-
Coeliac Disease Case–Control Study: Has the Time Come to Explore beyond Patients at Risk?
Nutrients, Vol. 15, Núm. 5
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
“Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”
Human Immunology, Vol. 84, Núm. 4, pp. 290-295
2022
-
Correlation of Anti-Tissue Transglutaminase Antibodies With the Mucosal Changes and IgA Status of Children With Celiac Disease
Journal of pediatric gastroenterology and nutrition, Vol. 75, Núm. 6, pp. 743-748
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
COVID-19: Critical appraisal of the evidence
Anales de Pediatria, Vol. 95, Núm. 3, pp. 207.e1-207.e13
2020
-
Digestive involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 110-115
-
Predictors of response to exclusive enteral nutrition in newly diagnosed crohn’s disease in children: PRESENCE Study from SEGHNP
Nutrients, Vol. 12, Núm. 4
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
-
Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica
Frontiers in Pediatrics, Vol. 8
-
The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain
Scientific Reports, Vol. 10, Núm. 1
2019
-
Diverse large HIV-1 non-subtype B clusters are spreading among men who have sex with men in Spain
Frontiers in Microbiology, Vol. 10, Núm. APR
2018
-
Human immunodeficiency virus/hepatits C virus coinfection in Spain: Elimination is feasible, but the burden of residual cirrhosis will be significant
Open Forum Infectious Diseases, Vol. 5, Núm. 1
-
Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study
Critical Care, Vol. 22, Núm. 1
2017
-
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 38-45
-
Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER)
Clinical and Experimental Rheumatology, Vol. 35, pp. 28-34